Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.43 |
| ▸ | GAA | P10253 | 1/20 | 0.43 |
| ▸ | MAPT | P10636 | 1/20 | 0.43 |
| ▸ | THRB | P10828 | 1/20 | 0.43 |
| ▸ | MGLL | Q99685 | 4/20 | 0.40 |
| ▸ | FAAH | O00519 | 3/20 | 0.40 |
| ▸ | GBA1 | P04062 | 2/20 | 0.39 |
| ▸ | PTGS1 | P23219 | 3/20 | 0.37 |
| ▸ | PTGS2 | P35354 | 3/20 | 0.37 |
| ▸ | ALOX5 | P09917 | 2/20 | 0.34 |
| ▸ | PLA2G2A | P14555 | 2/20 | 0.34 |
| ▸ | CYP1A2 | P05177 | 3/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5963734 | 0.94 | ALDH1A1 (0.37) | ALDH1A1GAAMAPTTHRBMGLL | |
| SCHEMBL5964167 | 0.86 | — | — | |
| SCHEMBL3970458 | 0.81 | ALDH1A1 (0.41) | ALDH1A1GAAMAPTTHRBMGLL | |
| SCHEMBL10978829 | 0.81 | — | — | |
| Hydrochloric Acid SCHEMBL28905052 | 0.79 | MGLL (0.39) | ALDH1A1GAAMAPTTHRBMGLL | |
| SCHEMBL1177851 | 0.78 | ALDH1A1 (0.35) | ALDH1A1 | |
| SCHEMBL5963570 | 0.77 | — | — | |
| SCHEMBL19233015 | 0.76 | MGLL (0.50) | ALDH1A1GAAMAPTTHRBMGLL | |
| SCHEMBL11701401 | 0.76 | TSHR (0.39) | ALDH1A1GAAMAPTTHRBCYP1A2 | |
| SCHEMBL31632712 | 0.74 | MGLL (0.52) | ALDH1A1GAAMAPTTHRBMGLL |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1064 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| JP-10147560-A | — | — | None | — | — | JP | disclosed |
| EP-2768456-B2 | FLUID-ABSORBENT ARTICLE | BASF SE (DE) | 2024-06-26 | — | — | EP | disclosed |
| US-12016761-B2 | Absorbent article with high absorbent material content | THE PROCTER & GAMBLE COMPANY (US) | 2024-06-25 | — | — | US | disclosed |
| US-11986798-B2 | Permeable superabsorbent and process for production thereof | BASF SE (DE) | 2024-05-21 | — | — | US | disclosed |
| US-20240148569-A1 | ABSORBENT STRUCTURE FOR ABSORBENT ARTICLES | PROCTER & GAMBLE (US) | 2024-05-09 | — | — | US | disclosed |
| US-11957551-B2 | Absorbent articles with channels and signals | THE PROCTER & GAMBLE COMPANY (US) | 2024-04-16 | — | — | US | disclosed |
| US-20240091078-A1 | ABSORBENT ARTICLE WITH HIGH ABSORBENT MATERIAL CONTENT | PROCTER & GAMBLE (US) | 2024-03-21 | — | — | US | disclosed |
| US-20240091073-A1 | DISPOSABLE ABSORBENT PANTS WITH ELASTICIZED WAIST PANEL STRUCTURE AND OBSCURING PRINT PATTERNS | THE PROCTER & GAMBLE COMPANY | 2024-03-21 | — | — | US | disclosed |
| US-11911250-B2 | Absorbent structure for absorbent articles | THE PROCTER & GAMBLE COMPANY (US) | 2024-02-27 | — | — | US | disclosed |
| US-20240058182-A1 | METHOD OF MAKING ABSORBENT STRUCTURES WITH CHANNELS | PROCTER & GAMBLE (US) | 2024-02-22 | — | — | US | disclosed |
| WO-2005097881-A1 | HIGHLY PERMEABLE SWELLABLE HYDROGEL-FORMING POLYMERS | BASF AKTIENGESELLSCHAFT (DE) | 2005-10-20 | — | — | WO | disclosed |
| WO-2005080479-A1 | METHOD FOR SECONDARY CROSSLINKING OF WATER-ABSORBENT POLYMERS | BASF AKTIENGESELLSCHAFT (DE) | 2005-09-01 | — | — | WO | disclosed |
| WO-2005075544-A1 | METHOD FOR PRODUCING ABSORBENT COMPOSITE MATERIALS | BASF AKTIENGESELLSCHAFT (DE) | 2005-08-18 | — | — | WO | disclosed |
| WO-2005061014-A1 | SWELLABLE HYDROGEL-FORMING POLYMERS HAVING A LOW FINE DUST CONCENTRATION | BASF AKTIENGESELLSCHAFT (DE) | 2005-07-07 | — | — | WO | disclosed |
| WO-2005019279-A1 | METHOD FOR THE SECONDARY CROSSLINKING OF HYDROGELS WITH BICYCLIC AMIDE ACETALS | BASF AKTIENGESELLSCHAFT (DE) | 2005-03-03 | — | — | WO | disclosed |
| EP-1436335-B1 | METHOD FOR CROSSLINKING HYDROGELS WITH MORPHOLINE-2,3-DIONES | BASF AG (DE) | 2005-01-26 | — | — | EP | disclosed |
| US-20040231065-A1 | Method for crosslinking hydrogels with morpholine-2,3-diones | BASF AKTIENGESELLSCHAFT, A GERMAN CORPORATION (DE) | 2004-11-25 | — | — | US | disclosed |
| EP-1436335-A1 | METHOD FOR CROSSLINKING HYDROGELS WITH MORPHOLINE-2,3-DIONES | BASF AKTIENGESELLSCHAFT (DE) | 2004-07-14 | — | — | EP | disclosed |
| WO-2003031482-A1 | METHOD FOR CROSSLINKING HYDROGELS WITH MORPHOLINE-2,3-DIONES | BASF AKTIENGESELLSCHAFT (DE) | 2003-04-17 | — | — | WO | disclosed |
| JP-H10147560-A | PRODUCTION OF N-2-BROMOETHYL-AMINOBENZOIC ACID DERIVATIVE | UBE IND LTD | 1998-06-02 | — | — | JP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040231065-A1 | Method for crosslinking hydrogels with morpholine-2,3-diones | ADM2, COL1A1, MDN1 | ALDH1A1 592/4885GAA 2937/4885MAPT 2083/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.